Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02431260
Title An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Incyte Corporation
Indications

Advanced Solid Tumor

lymphoma

Therapies

INCB054329

Age Groups: adult
Covered Countries USA


No variant requirements are available.